Clinical Study On The Treatment Of Infantile Purpuric Nephritis Proteinuria With

Objective:Observation on Henoch Schonlein purpura nephritis proteinuria in early and repeated period, the Didan decoction on purpura nephritis proteinuria (heat toxin stasis) treatment.Methods:60cases of children with Henoch Schonlein purpura nephritis (heat toxin stasis syndrome) were randomly divided into the treatment group, the positive drug control group with30cases in each.Treatment group and positive drug group were given the Didan decoction and prednisone for8weeks after treatment, the treatment group and the control group before and after treatment in diseases and syndromes, the Didan decoction in treatment of children with Henoch Schonlein purpura nephritis (heat toxin stasis syndrome) to evaluate the validity and clinical application.Results:Patients of the two groups in gender, age and disease duration of no statistical significance (P>0.05), with comparable. In the treatment of the primary disease of proteinuria and hematuria, TCM syndromes and auxiliary items, the treatment group and the control group after treatment group were statistically significant (P<0.05). Proteinuria efficacy of main disease:treatment group total effectiveness96.67%; the positive drug control group total effectiveness80%. The two groups was statistically significant (P<0.05), the significant difference in proteinuria efficacy of main symptoms, treatment group was superior to positive drug control group. Therapeutic effect of syndrome:in the experimental group, the total efficiency of100%; the positive drug control group total effectiveness96.67%. The two groups was statistically significant (P<0.05), in the aspects of syndrome curative effect, the test group was superior to positive drug control group.Conclusion:The Didan decoction in treatment of children with Henoch Schonlein purpura nephritis heat toxin stasis proteinuria curative effect, and has better guidance in the clinic.